NCT04614155 is a NA clinical trial of Educational Intervention in Healthy Subject, sponsored by M.D. Anderson Cancer Center.

Who is sponsoring NCT04614155?

NCT04614155 is sponsored by M.D. Anderson Cancer Center.

What drugs are being tested in NCT04614155?

Interventions in NCT04614155: Educational Intervention, HPV Self-Collection, Questionnaire Administration.

What condition does NCT04614155 study?

NCT04614155 studies Healthy Subject.

Is NCT04614155 still recruiting?

NCT04614155 is currently completed. Last updated 12 August 2025.

Last reviewed 2025-08-12 · How we verify

NCT04614155

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Project Self in Improving Cervical Cancer Screening Rates in Hispanic and African American Women

Completed NA Last updated 12 August 2025

What this trial tests

NA trial testing Educational Intervention in Healthy Subject in 40 participants. Completed in 8 August 2025.

Timeline

27 August 2019

Primary endpoint
8 August 2025

8 August 2025

Quick facts

Lead sponsor	M.D. Anderson Cancer Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	screening
Enrollment	40
Start date	27 August 2019
Primary completion	8 August 2025
Estimated completion	8 August 2025
Sites	1 location across United States

Drugs / interventions tested

Educational Intervention
HPV Self-Collection
Questionnaire Administration

Conditions studied

Healthy Subject — all drugs for Healthy Subject →

Sponsor

M.D. Anderson Cancer Center — full company profile →

Who can join

Adults 30 to 65, female only, with Healthy Subject. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial studies if Project Self can improve the rate of cervical cancer screening in Hispanic and African American women living in Houston, Texas. Project Self may help to improve cervical cancer screening rates by providing human papillomavirus (HPV) self-collection kits, education, counseling, and navigation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Culturally Competent Education and Human Papillomavirus Self-Sampling Achieves Healthy People 2030 Cervical Screening Target Among Low-Income Non-Hispanic Black and Hispanic Women.
Shastri SS, McNeill LH, Shete S. · · 2024 · cited 3× · PMID 38723214 · DOI 10.1200/go.24.00005

Verify or expand the search:

Other trials of Educational Intervention

Trials testing the same drug.

NCT07226102 — Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic o · NA · withdrawn
NCT07474090 — Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial · NA · not yet recruiting
NCT07490860 — A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to · NA · not yet recruiting
NCT07332312 — A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Ind · NA · not yet recruiting
NCT07176000 — Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington S · NA · not yet recruiting

Other recruiting trials for Healthy Subject

Currently open trials in the same condition.

NCT03897270 — Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects · NA · recruiting
NCT03303846 — Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients · NA · active not recruiting
NCT03491176 — Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer · active not recruiting
NCT03207854 — Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers · recruiting
NCT03199365 — Tu Salud Si Cuenta Intervention in Increasing Physical Activity and Healthy Eating Among Latino Families · NA · active not recruiting

Other M.D. Anderson Cancer Center trials

Trials by the same sponsor.

NCT07053020 — A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukem · Phase 1, PHASE2 · not yet recruiting
NCT07052994 — A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and · Phase 1 · not yet recruiting
NCT07137481 — Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Che · Phase 2 · not yet recruiting
NCT07162480 — Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Ca · Phase 2 · not yet recruiting
NCT07076498 — Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standar · Phase 1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04614155 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by M.D. Anderson Cancer Center
Last refreshed: 12 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04614155.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing